S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   302.98 (-0.16%)
AAPL   122.85 (+0.11%)
MSFT   214.17 (-0.94%)
FB   287.96 (+0.49%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,204.57 (-0.48%)
TSLA   560.67 (-4.12%)
NVDA   541.50 (+1.10%)
BABA   261.65 (-0.89%)
CGC   28.43 (+6.68%)
GE   10.35 (+1.97%)
MU   68.49 (+2.10%)
AMD   93.58 (+1.03%)
T   28.94 (+0.24%)
NIO   47.46 (+4.63%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.66 (-0.38%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.46 (+2.02%)
S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   302.98 (-0.16%)
AAPL   122.85 (+0.11%)
MSFT   214.17 (-0.94%)
FB   287.96 (+0.49%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,204.57 (-0.48%)
TSLA   560.67 (-4.12%)
NVDA   541.50 (+1.10%)
BABA   261.65 (-0.89%)
CGC   28.43 (+6.68%)
GE   10.35 (+1.97%)
MU   68.49 (+2.10%)
AMD   93.58 (+1.03%)
T   28.94 (+0.24%)
NIO   47.46 (+4.63%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.66 (-0.38%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.46 (+2.02%)
S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   302.98 (-0.16%)
AAPL   122.85 (+0.11%)
MSFT   214.17 (-0.94%)
FB   287.96 (+0.49%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,204.57 (-0.48%)
TSLA   560.67 (-4.12%)
NVDA   541.50 (+1.10%)
BABA   261.65 (-0.89%)
CGC   28.43 (+6.68%)
GE   10.35 (+1.97%)
MU   68.49 (+2.10%)
AMD   93.58 (+1.03%)
T   28.94 (+0.24%)
NIO   47.46 (+4.63%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.66 (-0.38%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.46 (+2.02%)
S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   302.98 (-0.16%)
AAPL   122.85 (+0.11%)
MSFT   214.17 (-0.94%)
FB   287.96 (+0.49%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,204.57 (-0.48%)
TSLA   560.67 (-4.12%)
NVDA   541.50 (+1.10%)
BABA   261.65 (-0.89%)
CGC   28.43 (+6.68%)
GE   10.35 (+1.97%)
MU   68.49 (+2.10%)
AMD   93.58 (+1.03%)
T   28.94 (+0.24%)
NIO   47.46 (+4.63%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.66 (-0.38%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.46 (+2.02%)
Log in
ARCA:CRHM

CRH Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume80,201 shs
Market Capitalization$185.05 million
P/E RatioN/A
Dividend YieldN/A
Beta2.31
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company also distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. It serves 64 ambulatory surgical/endoscopy centers in 13 states. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was incorporated in 2001 and is headquartered in Vancouver, Canada.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.29 out of 5 stars


Industry, Sector and Symbol

Industry Health services
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone604 633 1440
Employees149

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$120.39 million
Book Value$1.74 per share

Profitability

Net Income$3.77 million

Miscellaneous

Market Cap$185.05 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive CRHM News and Ratings via Email

Sign-up to receive the latest news and ratings for CRHM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CRH Medical (ARCA:CRHM) Frequently Asked Questions

What stocks does MarketBeat like better than CRH Medical?

Wall Street analysts have given CRH Medical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CRH Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of CRH Medical's key competitors?

Who are CRH Medical's key executives?

CRH Medical's management team includes the following people:
  • Dr. Tushar M. Ramani, Chairman & CEO (Age 56, Pay $979.77k)
  • Mr. Richard K. Bear, CFO & Corp. Sec. (Age 57, Pay $523.6k)
  • Mr. James T. Kreger, Pres of CRH Anesthesia Management (Age 51, Pay $366.39k)
  • Mr. Tom Sanders, VP of Commercial Devel.

What is CRH Medical's stock symbol?

CRH Medical trades on the ARCA under the ticker symbol "CRHM."

How do I buy shares of CRH Medical?

Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of $0.00 and generates $120.39 million in revenue each year. The company earns $3.77 million in net income (profit) each year or $0.05 on an earnings per share basis. CRH Medical employs 149 workers across the globe.

What is CRH Medical's official website?

The official website for CRH Medical is www.crhmedcorp.com.

How can I contact CRH Medical?

CRH Medical's mailing address is 619 - 999 CANADA PLACE WORLD TRADE CENTER, VANCOUVER A1, V6C 3E1. The company can be reached via phone at 604 633 1440 or via email at [email protected]

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.